Investment Analysts’ Updated EPS Estimates for November 5th (ABCL, ATSG, BCE, BCRX, BEN, CI, CLW, CRSR, CSGS, DOCN)

Investment Analysts’ updated eps estimates for Tuesday, November 5th:

AbCellera Biologics (NASDAQ:ABCL) had its hold rating reaffirmed by analysts at Benchmark Co..

AbCellera Biologics (NASDAQ:ABCL) had its buy rating reaffirmed by analysts at Stifel Nicolaus. They currently have a $12.00 target price on the stock, down from their previous target price of $14.00.

Air Transport Services Group (NASDAQ:ATSG) had its hold rating reiterated by analysts at Loop Capital. The firm currently has a $22.50 target price on the stock, up from their previous target price of $22.00.

BCE (NYSE:BCE) (TSE:BCE) had its hold rating reiterated by analysts at Canaccord Genuity Group Inc..

BioCryst Pharmaceuticals (NASDAQ:BCRX) had its buy rating reaffirmed by analysts at Needham & Company LLC. They currently have a $14.00 price target on the stock.

BioCryst Pharmaceuticals (NASDAQ:BCRX) had its outperform rating reissued by analysts at Royal Bank of Canada. They currently have a $10.00 price target on the stock.

Franklin Resources (NYSE:BEN) had its underperform rating reiterated by analysts at Keefe, Bruyette & Woods. The firm currently has a $19.00 target price on the stock, down from their previous target price of $20.00.

The Cigna Group (NYSE:CI) had its overweight rating reissued by analysts at Piper Sandler. Piper Sandler currently has a $394.00 price target on the stock, up from their previous price target of $392.00.

Clearwater Paper (NYSE:CLW) had its outperform rating reiterated by analysts at Royal Bank of Canada. The firm currently has a $37.00 price target on the stock.

Corsair Gaming (NASDAQ:CRSR) had its outperform rating reaffirmed by analysts at Wedbush. Wedbush currently has a $11.00 target price on the stock.

CSG Systems International (NASDAQ:CSGS) had its buy rating reaffirmed by analysts at Benchmark Co.. Benchmark Co. currently has a $75.00 target price on the stock.

DigitalOcean (NYSE:DOCN) had its hold rating reissued by analysts at Needham & Company LLC.

ESCO Technologies (NYSE:ESE) had its buy rating reissued by analysts at Benchmark Co.. Benchmark Co. currently has a $150.00 price target on the stock.

EVE (NYSE:EVEX) had its overweight rating reissued by analysts at Cantor Fitzgerald. They currently have a $5.00 price target on the stock.

FOX (NASDAQ:FOXA) had its neutral rating reiterated by analysts at Macquarie. The firm currently has a $43.00 price target on the stock.

The Hackett Group (NASDAQ:HCKT) had its outperform rating reissued by analysts at Barrington Research. Barrington Research currently has a $28.00 price target on the stock.

Hudson Technologies (NASDAQ:HDSN) had its neutral rating reissued by analysts at B. Riley. The firm currently has a $7.25 price target on the stock, down from their previous price target of $8.50.

Hims & Hers Health (NYSE:HIMS) had its neutral rating reiterated by analysts at Piper Sandler. They currently have a $21.00 price target on the stock, up from their previous price target of $18.00.

Heidrick & Struggles International (NASDAQ:HSII) had its hold rating reaffirmed by analysts at Truist Financial Co.. The firm currently has a $40.00 target price on the stock, up from their previous target price of $33.00.

Ichor (NASDAQ:ICHR) had its buy rating reaffirmed by analysts at B. Riley. They currently have a $38.00 price target on the stock, up from their previous price target of $36.00.

Inspire Medical Systems (NYSE:INSP) had its overweight rating reiterated by analysts at Piper Sandler. Piper Sandler currently has a $260.00 price target on the stock, up from their previous price target of $255.00.

Inspire Medical Systems (NYSE:INSP) had its hold rating reaffirmed by analysts at Stifel Nicolaus. The firm currently has a $200.00 price target on the stock, up from their previous price target of $170.00.

Inspire Medical Systems (NYSE:INSP) had its outperform rating reissued by analysts at Royal Bank of Canada. Royal Bank of Canada currently has a $260.00 target price on the stock.

Intapp (NASDAQ:INTA) had its overweight rating reiterated by analysts at Piper Sandler. They currently have a $60.00 target price on the stock, up from their previous target price of $46.00.

Intapp (NASDAQ:INTA) had its buy rating reiterated by analysts at Truist Financial Co.. They currently have a $55.00 target price on the stock, up from their previous target price of $47.00.

Disc Medicine (NASDAQ:IRON) had its buy rating reaffirmed by analysts at HC Wainwright. HC Wainwright currently has a $70.00 price target on the stock.

Krystal Biotech (NASDAQ:KRYS) had its buy rating reissued by analysts at HC Wainwright. HC Wainwright currently has a $221.00 price target on the stock.

Landsea Homes (NASDAQ:LSEA) had its buy rating reissued by analysts at B. Riley. The firm currently has a $18.00 price target on the stock, up from their previous price target of $17.00.

Lexicon Pharmaceuticals (NASDAQ:LXRX) had its buy rating reissued by analysts at HC Wainwright. They currently have a $6.00 target price on the stock.

Marriott International (NASDAQ:MAR) had its neutral rating reissued by analysts at Macquarie. They currently have a $245.00 price target on the stock.

MoonLake Immunotherapeutics (NASDAQ:MLTX) had its outperform rating reaffirmed by analysts at Wedbush. Wedbush currently has a $73.00 price target on the stock, down from their previous price target of $92.00.

Microsoft (NASDAQ:MSFT) had its outperform rating reissued by analysts at Royal Bank of Canada. The firm currently has a $500.00 price target on the stock.

MasTec (NYSE:MTZ) had its buy rating reissued by analysts at B. Riley. B. Riley currently has a $166.00 price target on the stock, up from their previous price target of $151.00.

Nyxoah (NASDAQ:NYXH) had its overweight rating reaffirmed by analysts at Cantor Fitzgerald. They currently have a $16.00 target price on the stock.

Root (NASDAQ:ROOT) had its outperform rating reissued by analysts at Keefe, Bruyette & Woods. The firm currently has a $90.00 price target on the stock, up from their previous price target of $82.00.

Silicon Laboratories (NASDAQ:SLAB) had its hold rating reissued by analysts at Benchmark Co..

Teradata (NYSE:TDC) had its sector perform rating reiterated by analysts at Royal Bank of Canada. Royal Bank of Canada currently has a $32.00 price target on the stock.

TriMas (NASDAQ:TRS) had its buy rating reiterated by analysts at BWS Financial. They currently have a $40.00 target price on the stock.

Vimeo (NASDAQ:VMEO) had its neutral rating reaffirmed by analysts at Piper Sandler. Piper Sandler currently has a $7.00 price target on the stock, up from their previous price target of $5.00.

Vertex Pharmaceuticals (NASDAQ:VRTX) had its overweight rating reiterated by analysts at Cantor Fitzgerald. They currently have a $480.00 target price on the stock.

V2X (NYSE:VVX) had its outperform rating reiterated by analysts at Royal Bank of Canada. The firm currently has a $70.00 target price on the stock.

Wynn Resorts (NASDAQ:WYNN) had its outperform rating reaffirmed by analysts at Macquarie. Macquarie currently has a $120.00 target price on the stock.